RO 20-1724
RO 20-1724 structure
|
Common Name | RO 20-1724 | ||
|---|---|---|---|---|
| CAS Number | 29925-17-5 | Molecular Weight | 278.35 | |
| Density | 1.099 g/cm3 | Boiling Point | 483.8ºC at 760 mmHg | |
| Molecular Formula | C15H22N2O3 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 246.4ºC | |
Use of RO 20-1724Ro 20-1724 (Ro 20-174) is a potent inhibitor of cAMP-specific phosphodiesterase (PDE4/PDE IV) with a Ki of 1930 nM. Neuroprotective effect[1][2]. |
| Name | 4-(3-Butoxy-4-methoxybenzyl)imidazolidin-2-one |
|---|---|
| Synonym | More Synonyms |
| Description | Ro 20-1724 (Ro 20-174) is a potent inhibitor of cAMP-specific phosphodiesterase (PDE4/PDE IV) with a Ki of 1930 nM. Neuroprotective effect[1][2]. |
|---|---|
| Related Catalog | |
| Target |
PDE4:1930 nM (Ki) |
| In Vivo | Ro 20-1724 (125, 250 and 500 μg/kg; i.p.; 21 days following first i.c.v. streptozotocin administration; 200-250 g adult (3-5 months old) male albino Wistar rats) significantly attenuated streptozotocin induced cognitive deficit and oxidative stress[2]. |
| References |
| Density | 1.099 g/cm3 |
|---|---|
| Boiling Point | 483.8ºC at 760 mmHg |
| Molecular Formula | C15H22N2O3 |
| Molecular Weight | 278.35 |
| Flash Point | 246.4ºC |
| Exact Mass | 278.16300 |
| PSA | 59.59000 |
| LogP | 2.75560 |
| Vapour Pressure | 1.62E-09mmHg at 25°C |
| Index of Refraction | 1.521 |
| Storage condition | Store at RT |
| Water Solubility | ethanol: 7 mg/mL |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
|---|---|
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2933990090 |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Impairment of adenylyl cyclase-mediated glutamatergic synaptic plasticity in the periaqueductal grey in a rat model of neuropathic pain.
J. Physiol. 593 , 2955-73, (2015) Long-lasting neuropathic pain has been attributed to elevated neuronal plasticity changes in spinal, peripheral and cortical levels. Here, we found that reduced neuronal plasticity in the ventrolatera... |
|
|
Adaptation of NS cells growth and differentiation to high-throughput screening-compatible plates.
BMC Neurosci. 11 , 7, (2010) There is an urgent need of neuronal cell models to be applied to high-throughput screening settings while recapitulating physiological and/or pathological events occurring in the Central Nervous Syste... |
|
|
Characterization of Dahl salt-sensitive rats with genetic disruption of the A2B adenosine receptor gene: implications for A2B adenosine receptor signaling during hypertension.
Purinergic Signal. 11 , 519-31, (2015) The A(2B) adenosine receptor (AR) has emerged as a unique member of the AR family with contrasting roles during acute and chronic disease states. We utilized zinc-finger nuclease technology to create ... |
| MFCD00077397 |
| 4-[(3-butoxy-4-methoxyphenyl)methyl]-2-imidazolidinone |